Finished Dosage Forms vs. APIs: What’s the Difference in Pharmaceutical Manufacturing?
Explore the key differences between Finished Dosage Forms (FDFs) and APIs in drug development and manufacturing.
PR
Upperton Named in The Sunday Times Best Places To Work 2025 Accreditation
We’re delighted to share that Upperton has officially been accredited as on of the Sunday Time Best Places to Work 2025
Upperton Pharma Solutions Named One of The Sunday Times Best Places to Work 2025
We’re delighted to announce that Upperton has officially been accredited as one of The Sunday Times Best Places to Work 2025
Step inside Upperton’s R&D Laboratories
Our Approach Project Initiation and Onboarding We typically initiate projects within two to three weeks of proposal acceptance. During this time, we manage project onboarding and procure any necessary materials. Our analytical team plays a crucial role in onboarding new methods, confirming their suitability, and ensuring readiness for the subsequent stages of your project. This … Read more
Upperton Continues Strategic Growth with the Appointment of Michael Mellor-Clark as Chief Commercial Officer.
Upperton continues growth with appointment of Michael Mellor-Clark as Chief Commercial Officer.
Management Spotlight with Laura Mason
Discover more about our team. In this Spotlight, meet our Director of Pharmaceutical Sciences, Laura Mason, on her journey with Upperton.
Upperton Pharma Solutions Named Champion Award Winner in 2025 CDMO Leadership Awards
Upperton is proud to announce its recognition as the Champion Award Winner in the Small Molecule Dosage Form category at the CDMO Leadership Awards.
Upperton Announced as ‘Excellence in Innovation’ Finalist in Medilink Midlands Business Awards 2025
We are delighted to share that we have been shortlisted as a finalist in the Excellence in Innovation category at the Medilink Midlands Business Awards 2025.
How CDMOs Drive CMC Success in Drug Development
Addressing CMC considerations early in the drug development process is vital in the successful creation of a pharmaceutical product.
CMC Considerations for Early-Stage Drug Development
Addressing CMC considerations early in the drug development process is vital in the successful creation of a pharmaceutical product.
